Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Retrospective review of carvedilol administration in 38 dogs with preclinical chronic valvular heart disease.

Gordon SG, Saunders AB, Hariu CD, Boggess MM, Miller MW.

J Vet Cardiol. 2012 Mar;14(1):243-52. doi: 10.1016/j.jvc.2012.01.007. Epub 2012 Feb 23.

PMID:
22364694
[PubMed - indexed for MEDLINE]
2.

Effects of carvedilol treatment in dogs with chronic mitral valvular disease.

Marcondes-Santos M, Tarasoutchi F, Mansur AP, Strunz CM.

J Vet Intern Med. 2007 Sep-Oct;21(5):996-1001.

PMID:
17939555
[PubMed - indexed for MEDLINE]
3.

Cardiovascular and renal effects of carvedilol in dogs with heart failure.

Uechi M, Sasaki T, Ueno K, Yamamoto T, Ishikawa Y.

J Vet Med Sci. 2002 Jun;64(6):469-75.

PMID:
12130829
[PubMed - indexed for MEDLINE]
Free Article
4.

Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.

Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.

Am Heart J. 2000 Apr;139(4):596-608.

PMID:
10740140
[PubMed - indexed for MEDLINE]
5.

Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.

Bajcetic M, Kokic Nikolic A, Djukic M, Kosutic J, Mitrovic J, Mijalkovic D, Jovanovic I, Simeunovic S, Spasic MB, Samardzic R.

Clin Ther. 2008 Apr;30(4):702-14.

PMID:
18498919
[PubMed - indexed for MEDLINE]
6.

Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.

Macdonald PS, Keogh AM, Aboyoun CL, Lund M, Amor R, McCaffrey DJ.

J Am Coll Cardiol. 1999 Mar 15;33(4):924-31.

PMID:
10091817
[PubMed - indexed for MEDLINE]
Free Article
7.

Carvedilol in dogs with dilated cardiomyopathy.

Oyama MA, Sisson DD, Prosek R, Bulmer BJ, Luethy MW, Fuentes VL.

J Vet Intern Med. 2007 Nov-Dec;21(6):1272-9.

PMID:
18196737
[PubMed - indexed for MEDLINE]
8.

Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.

Krum H, Ninio D, MacDonald P.

Heart. 2000 Dec;84(6):615-9.

PMID:
11083738
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure].

Kawashiro N, Matsuda N, Endo Y, Uchida Y, Kasanuki H.

J Cardiol. 2006 May;47(5):229-37. Japanese.

PMID:
16764329
[PubMed - indexed for MEDLINE]
10.

The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design.

Shaddy RE, Curtin EL, Sower B, Tani LY, Burr J, LaSalle B, Boucek MM, Mahony L, Hsu DT, Pahl E, Burch GH, Schlencker-Herceg R.

Am Heart J. 2002 Sep;144(3):383-9.

PMID:
12228773
[PubMed - indexed for MEDLINE]
11.

Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment.

Azeka E, Franchini Ramires JA, Valler C, Alcides Bocchi E.

J Am Coll Cardiol. 2002 Dec 4;40(11):2034-8.

PMID:
12475466
[PubMed - indexed for MEDLINE]
Free Article
12.

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

Rouleau JL, Roecker EB, Tendera M, Mohacsi P, Krum H, Katus HA, Fowler MB, Coats AJ, Castaigne A, Scherhag A, Holcslaw TL, Packer M; Carvedilol Prospective Randomized Cumulative Survival Study Group.

J Am Coll Cardiol. 2004 Apr 21;43(8):1423-9.

PMID:
15093878
[PubMed - indexed for MEDLINE]
Free Article
13.

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.

J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.

PMID:
20413026
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter.

Kotlyar E, Hayward CS, Keogh AM, Feneley M, Macdonald PS.

Heart. 2004 Jul;90(7):800-1. No abstract available.

PMID:
15201254
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation.

Pamboukian SV, Aminbakhsh A, Thompson CR, Amin H, Mortimer S, D'yachkova Y, Ignaszweski AP.

Clin Transplant. 1999 Oct;13(5):426-31.

PMID:
10515224
[PubMed - indexed for MEDLINE]
17.

Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.

Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM.

Am J Cardiol. 1999 Apr 15;83(8):1201-5.

PMID:
10215284
[PubMed - indexed for MEDLINE]
18.

Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.

Razzolini R, Tarantini G, Boffa GM, Orlando S, Iliceto S.

Ital Heart J. 2004 Jul;5(7):517-22.

PMID:
15487269
[PubMed - indexed for MEDLINE]
19.

Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience.

Lainscak M, Moullet C, Schön N, Tendera M.

Int J Cardiol. 2007 Nov 15;122(2):149-55. Epub 2007 Sep 4.

PMID:
17804098
[PubMed - indexed for MEDLINE]
20.

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.

Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, Woo KS.

J Am Coll Cardiol. 1999 Nov 1;34(5):1522-8.

PMID:
10551702
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk